BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang JF, Dai DQ. Metastatic suppressor genes inactivated by aberrant methylation in gastric cancer. World J Gastroenterol 2007; 13(43): 5692-5698 [PMID: 17963294 DOI: 10.3748/wjg.v13.i43.5692]
URL: https://www.wjgnet.com/1007-9327/full/v13/i43/5692.htm
Number Citing Articles
1
Fang Ren, Dan-Bo Wang, Tong Li, Ying-Han Chen, Yan Li. Identification of differentially methylated genes in the malignant transformation of ovarian endometriosisJournal of Ovarian Research 2014; 7(1) doi: 10.1186/1757-2215-7-73
2
Theodore E. Whitmore, Amelia Peterson, Ted Holzman, Ashley Eastham, Lynn Amon, Martin McIntosh, Adrian Ozinsky, Peter S. Nelson, Daniel B. Martin. Integrative Analysis of N-Linked Human Glycoproteomic Data Sets Reveals PTPRF Ectodomain as a Novel Plasma Biomarker Candidate for Prostate CancerJournal of Proteome Research 2012; 11(5): 2653 doi: 10.1021/pr201200n
3
Hong Lok Lung, Arthur Kwok Leung Cheung, Josephine Mun Yee Ko, Yue Cheng, Eric J. Stanbridge, Maria Li Lung. Deciphering the molecular genetic basis of NPC through functional approachesSeminars in Cancer Biology 2012; 22(2): 87 doi: 10.1016/j.semcancer.2011.11.002
4
J Stebbing, L C Lit, H Zhang, R S Darrington, O Melaiu, B Rudraraju, G Giamas. The regulatory roles of phosphatases in cancerOncogene 2014; 33(8): 939 doi: 10.1038/onc.2013.80
5
Mohamed A. Ismail, Muthanna Samara, Ali Al Sayab, Mohamed Alsharshani, Mohamed A. Yassin, Govindarajulu Varadharaj, Marzia Vezzalini, Luisa Tomasello, Maria Monne, Hisham Morsi, M. Walid Qoronfleh, Hatem Zayed, Richard Cook, Claudio Sorio, Helmout Modjtahedi, Nader I. Al‐Dewik. Aberrant DNA methylation of PTPRG as one possible mechanism of its under‐expression in CML patients in the State of QatarMolecular Genetics & Genomic Medicine 2020; 8(10) doi: 10.1002/mgg3.1319
6
L. Benesova, B. Belsanova, S. Suchanek, M. Kopeckova, P. Minarikova, L. Lipska, M. Levy, V. Visokai, M. Zavoral, M. Minarik. Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patientsAnalytical Biochemistry 2013; 433(2): 227 doi: 10.1016/j.ab.2012.06.018
7
TAKASHI SATO, KENZO SOEJIMA, ERI ARAI, JUNKO HAMAMOTO, HIROYUKI YASUDA, DAISUKE ARAI, KOTA ISHIOKA, KEIKO OHGINO, KATSUHIKO NAOKI, TAKASHI KOHNO, KOJI TSUTA, SHUN-ICHI WATANABE, YAE KANAI, TOMOKO BETSUYAKU. Prognostic implication of PTPRH hypomethylation in non-small cell lung cancerOncology Reports 2015; 34(3): 1137 doi: 10.3892/or.2015.4082
8
Arthur Kwok Leung Cheung, Hong Lok Lung, Siu Chun Hung, Evan Wai Lok Law, Yue Cheng, Wing Lung Yau, Dhinoth Kumar Bangarusamy, Lance D. Miller, Edison Tak-Bun Liu, Jian-Yong Shao, Chang-Wei Kou, Daniel Chua, Eugene R. Zabarovsky, Sai Wah Tsao, Eric J. Stanbridge, Maria Li Lung. Functional Analysis of a Cell Cycle–Associated, Tumor-Suppressive Gene, Protein Tyrosine Phosphatase Receptor Type G, in Nasopharyngeal CarcinomaCancer Research 2008; 68(19): 8137 doi: 10.1158/0008-5472.CAN-08-0904
9
Andrew W. Stoker. Protein Tyrosine Phosphatases in Cancer2016; : 13 doi: 10.1007/978-1-4939-3649-6_2
10
Eddy H J van Roon, Noël F C C de Miranda, Merlijn P van Nieuwenhuizen, Emile J de Meijer, Marjo van Puijenbroek, Pearlly S Yan, Tim H-M Huang, Tom van Wezel, Hans Morreau, Judith M Boer. Tumour-specific methylation of PTPRG intron 1 locus in sporadic and Lynch syndrome colorectal cancerEuropean Journal of Human Genetics 2011; 19(3): 307 doi: 10.1038/ejhg.2010.187
11
DANJIE ZHANG, WEI ZHAO, XINHUA LIAO, TIEQIANG BI, HAIJUN LI, XIANGMING CHE. Frequent silencing of protocadherin 8 by promoter methylation, a candidate tumor suppressor for human gastric cancerOncology Reports 2012; 28(5): 1785 doi: 10.3892/or.2012.1997
12
Arthur Kwok Leung Cheung, Joseph Chok Yan Ip, Adrian Chi Hang Chu, Yue Cheng, Merrin Man Long Leong, Josephine Mun Yee Ko, Wai Ho Shuen, Hong Lok Lung, Maria Li Lung. PTPRG suppresses tumor growth and invasion via inhibition of Akt signaling in nasopharyngeal carcinomaOncotarget 2015; 6(15): 13434 doi: 10.18632/oncotarget.3876
13
Sofi G. Julien, Nadia Dubé, Serge Hardy, Michel L. Tremblay. Inside the human cancer tyrosine phosphatomeNature Reviews Cancer 2011; 11(1): 35 doi: 10.1038/nrc2980
14
M F Montenegro, L Sánchez-del-Campo, R González-Guerrero, E Martínez-Barba, A Piñero-Madrona, J Cabezas-Herrera, J N Rodríguez-López. Tumor suppressor SET9 guides the epigenetic plasticity of breast cancer cells and serves as an early-stage biomarker for predicting metastasisOncogene 2016; 35(47): 6143 doi: 10.1038/onc.2016.154
15
Mariana Tannús Ruckert, Pamela Viani de Andrade, Verena Silva Santos, Vanessa Silva Silveira. Protein tyrosine phosphatases: promising targets in pancreatic ductal adenocarcinomaCellular and Molecular Life Sciences 2019; 76(13): 2571 doi: 10.1007/s00018-019-03095-4
16
Stefano Piatto Clerici, Patrícia Fernandes de Souza Oliveira, Erica Mie Akagi, Helon Guimarães Cordeiro, Jordana Maria Azevedo-Martins, Alessandra Valéria de Sousa Faria, Carmen Veríssima Ferreira-Halder. A comprehensive review on the role of protein tyrosine phosphatases in gastric cancer development and progressionBiological Chemistry 2021; 402(6): 663 doi: 10.1515/hsz-2020-0355
17
Lee B. Riley, David W. Anderson. Handbook of Epigenetics2011; : 521 doi: 10.1016/B978-0-12-375709-8.00032-0